Aizong Shen
Overview
Explore the profile of Aizong Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu C, Wu Y, Geng Y, Yan H, Zhu P, Ji P, et al.
Health Econ Rev
. 2025 Jan;
15(1):2.
PMID: 39792238
Background: The ORIENT-15 double-blind randomized controlled trial demonstrated that the addition of sintilimab to chemotherapy for locally advanced or metastatic oesophageal squamous cell carcinoma (OSCC) resulted in better clinical outcomes....
2.
Hong W, Shen A, Zheng M, Zhu W, Ma G
Int J Technol Assess Health Care
. 2024 Dec;
:1-23.
PMID: 39617637
No abstract available.
3.
Zhang F, Shen A, Ahmed W, Pollock R
Adv Ther
. 2024 Sep;
41(11):4191-4204.
PMID: 39292421
Introduction: Intravenous (IV) iron is the recommended treatment for patients with iron deficiency anemia (IDA) unresponsive to oral iron treatment, in whom oral iron is contraindicated, or where rapid iron...
4.
Deng T, Zhang L, Shi Y, Bai G, Pan Y, Shen A, et al.
Invest New Drugs
. 2023 Oct;
41(6):808-815.
PMID: 37889382
Pemigatinib is a selective fibroblast growth factor receptor (FGFR)1-3 inhibitor and has demonstrated acceptable tolerability and clinical activity in advanced solid tumors in Western population. This phase I trial evaluated...
5.
Ge P, Duan H, Tao C, Niu S, Hu Y, Duan R, et al.
J Inflamm Res
. 2023 Sep;
16:3699-3714.
PMID: 37663757
Objective: Stroke is a kind of cerebrovascular disease with high mortality. TMAO has been shown to aggravate stroke outcomes, but its mechanism remains unclear. Materials And Methods: Mice were fed...
6.
Zhu W, Zheng M, Xia P, Hong W, Ma G, Shen A
Front Oncol
. 2023 Mar;
13:1068463.
PMID: 36998437
Aim: To evaluate the cost-effectiveness of palbociclib plus fulvestrant in the second-line treatment of women with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer based on...
7.
Shi Y, Wang R, Wang L, Liu Q, Han L, Duan X, et al.
Eur J Pharmacol
. 2022 Dec;
939:175477.
PMID: 36543286
Ischemic stroke (IS) is the leading cause of long-term disability in the world and characterized by high morbidity, recurrence, complications, and mortality. Due to the lack of early diagnostic indicators,...
8.
Jin D, Liu M, Zhang M, Yu W, Yu J, Shen A, et al.
Adv Drug Deliv Rev
. 2022 Dec;
192:114648.
PMID: 36513163
Enzyme-mimicking nanocatalysts, also termed nanozymes, have attracted much attention in recent years. They are considered potential alternatives to natural enzymes due to their multiple catalytic activities and high stability. However,...
9.
Shi Y, Liu Q, Chen W, Wang R, Wang L, Liu Z, et al.
J Ethnopharmacol
. 2022 Oct;
301:115784.
PMID: 36206870
Ethnopharmacological Relevance: Taohong Siwu Decoction (THSWD) is a traditional Chinese medicine formula used to invigorate blood circulation and resolve blood stasis. It consists of Paeonia lactiflora Pall., Conioselinum anthriscoides (H.Boissieu)...
10.
Cen J, Ye X, Liu X, Pan W, Zhang L, Zhang G, et al.
Angew Chem Int Ed Engl
. 2022 Aug;
61(41):e202209610.
PMID: 35976720
Gas-filled microbubbles (MBs) have been clinically used as ultrasound (US) contrast agents for disease diagnosis and treatment. However, it remains a great challenge to resolve the dilemma of stability and...